Cyclin-dependent kinase 5 regulates E2F transcription factor through phosphorylation of Rb protein in neurons

Cell Cycle

Volumn 11, Issue 8, 2012, Pages 1603-1610

  Futatsugi, Akira ^a,c   Utreras, Elias ^a   Rudrabhatla, Parvathi ^b   Jaffe, Howard ^b   Pant, Harish C ^b   Kulkarni, Ashok B ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c KOBE CITY COLLEGE OF NURSING   (Japan)

Author keywords

Cdk5; Cell cycle; Cell death; E2F transcription factor; Neurons; Phosphorylation; Retinoblastoma protein

Indexed keywords

CYCLIN D; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 5; CYCLIN E; PROTEIN P25; PROTEIN P35; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE REGULATION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; MASS SPECTROMETRY; MITOSIS; MOLECULAR MODEL; MOUSE; NERVE CELL; NERVE CELL NECROSIS; NONHUMAN; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; TRANSCRIPTION INITIATION;

EID: 84860342022     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.20009     Document Type: Article

References (50)

1. Nevins JR. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992; 258:424-9; PMID:1411535; http://dx.doi.org/10.1126/ science.1411535.
2. 1. Cell 1999; 98:859-69; PMID:10499802; http://dx.doi.org/10.1016/S0092-8674(00)81519-6.
3. Nishitani H, Lygerou Z. Control of DNA replication licensing in a cell cycle. Genes Cells 2002; 7:523-34; PMID:12059957; http://dx.doi.org/10.1046/j. 1365-2443.2002.00544.x.
4. Hook SS, Lin JJ, Dutta A. Mechanisms to control rereplication and implications for cancer. Curr Opin Cell Biol 2007; 19:663-71; PMID:18053699; http:// dx.doi.org/10.1016/j.ceb.2007.10.007.
5. Nigg EA. Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol 2001; 2:21-32; PMID:11413462; http://dx.doi.org/10.1038/35048096.
6. Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, et al. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci USA 1996; 93:11173-8; PMID:8855328; http://dx.doi.org/10.1073/pnas.93.20.11173.
7. Harada T, Morooka T, Ogawa S, Nishida E. ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat Cell Biol 2001; 3:453-9; PMID:11331872; http://dx.doi.org/10.1038/35074516.
8. Li BS, Sun MK, Zhang L, Takahashi S, Ma W, Vinade L, et al. Regulation of NMDA receptors by cyclin-dependent kinase-5. Proc Natl Acad Sci USA 2001; 98:12742-7; PMID:11675505; http://dx.doi.org/10.1073/pnas.211428098.
9. Cicero S, Herrup K. Cyclin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation. J Neurosci 2005; 25:9658-68; PMID:16237170; http:// dx.doi.org/10.1523/JNEUROSCI.1773-05.2005.
10. Takahashi S, Ohshima T, Hirasawa M, Pareek TK, Bugge TH, Morozov A, et al. Conditional deletion of neuronal cyclin-dependent kinase 5 in developing forebrain results in microglial activation and neurodegeneration. Am J Pathol 2010; 176:320-9; PMID:19948833; http://dx.doi.org/10.2353/ajpath.2010.081158.
11. Brinkkoetter PT, Pippin JW, Shankland SJ. Cyclin I-Cdk5 governs survival in post-mitotic cells. Cell Cycle 2010; 9:1729-31; PMID:20404535; http:// dx.doi.org/10.4161/cc.9.9.11471.
12. Trunova S, Giniger E. Absence of the Cdk5 activator p35 causes adult-onset neurodegeneration in the central brain of Drosophila. Dis Model Mech 2012; 5:210-9; PMID:22228754; http://dx.doi.org/10.1242/ dmm.008847.
13. Pareek TK, Keller J, Kesavapany S, Pant HC, Iadarola MJ, Brady RO, et al. Cyclin-dependent kinase 5 activity regulates pain signaling. Proc Natl Acad Sci USA 2006; 103:791-6; PMID:16407116; http://dx.doi. org/10.1073/pnas.0510405103.
14. Pareek TK, Keller J, Kesavapany S, Agarwal N, Kuner R, Pant HC, et al. Cyclin-dependent kinase 5 modulates nociceptive signaling through direct phosphorylation of transient receptor potential vanilloid 1. Proc Natl Acad Sci USA 2007; 104:660-5; PMID:17194758; http:// dx.doi.org/10.1073/pnas.0609916104.
15. Utreras E, Futatsugi A, Rudrabhatla P, Keller J, Iadarola MJ, Pant HC, et al. Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35. J Biol Chem 2009; 284:2275-84; PMID:19049962; http:// dx.doi.org/10.1074/jbc.M805052200.
16. Lee KY, Helbing CC, Choi KS, Johnston RN, Wang JH. Neuronal Cdc2-like kinase (Nclk) binds and phosphorylates the retinoblastoma protein. J Biol Chem 1997; 272:5622-6; PMID:9038171; http://dx.doi.org/10.1074/jbc.272.9.5622.
17. Gong X, Tang X, Wiedmann M, Wang X, Peng J, Zheng D, et al. Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity- induced apoptosis. Neuron 2003; 38:33-46; PMID:12691662; http://dx.doi.org/10.1016/S0896-6273(03)00191-0.
18. Hamdane M, Bretteville A, Sambo AV, Schindowski K, Bégard S, Delacourte A, et al. p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death. J Cell Sci 2005; 118:1291-8; PMID:15741232; http://dx.doi.org/10.1242/jcs.01724.
19. kip1 contributing to actin organization and cortical neuronal migration. Nat Cell Biol 2006; 8:17-26; PMID:16341208; http:// dx.doi.org/10.1038/ncb1338.
20. Tian B, Yang Q, Mao Z. Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death. Nat Cell Biol 2009; 11:211-8; PMID:19151707; http://dx.doi.org/10.1038/ncb1829.
21. Huang E, Qu D, Park DS. Cdk5: Links to DNA damage. Cell Cycle 2010; 9:3142-3; PMID:20724832; http://dx.doi.org/10.4161/cc.9.16.12955.
22. -/- cells. Cell Cycle 2010; 9:3629-30; PMID:20703088; http://dx.doi.org/10.4161/cc.9.17.12722.
23. Kim T, Law V, Rosales JL, Lee KY. Cdk5 variant 1 (cdk5-v1), but not full-length cdk5, is a centrosomal protein. Cell Cycle 2010; 9:2251-3; PMID:20495369; http://dx.doi.org/10.4161/cc.9.11.11652.
24. Rosales JL, Rattner JB, Lee KY. Cdk5 in the centriolar appendages mediates cenexin1 localization and primary cilia formation. Cell Cycle 2010; 9:2037-9; PMID:20234188; http://dx.doi.org/10.4161/cc.9.10.11600.
25. Zhang J, Herrup K. Nucleocytoplasmic Cdk5 is involved in neuronal cell cycle and death in post-mitotic neurons. Cell Cycle 2011; 10:1208-14; PMID:21415596; http://dx.doi.org/10.4161/cc.10.8.15328.
26. Zhang J, Li H, Herrup K. Cdk5 nuclear localization is p27-dependent in nerve cells: implications for cell cycle suppression and caspase-3 activation. J Biol Chem 2010; 285:14052-61; PMID:20189989; http://dx.doi. org/10.1074/jbc.M109.068262.
27. Zhang J, Li H, Yabut O, Fitzpatrick H, D'Arcangelo G, Herrup K. Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex. J Neurosci 2010; 30:5219-28; PMID:20392944; http://dx.doi.org/10.1523/JNEUROSCI. 5628-09.2010.
28. Zhang J, Herrup K. Cdk5 and the non-catalytic arrest of the neuronal cell cycle. Cell Cycle 2008; 7:3487-90; PMID:19001851; http://dx.doi.org/10.4161/cc. 7.22.7045.
29. Zhang J, Cicero SA, Wang L, Romito-Digiacomo RR, Yang Y, Herrup K. Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons. Proc Natl Acad Sci USA 2008; 105:8772-7; PMID:18550843; http://dx.doi.org/10.1073/pnas.0711355105.
30. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 1999; 402:615-22; PMID:10604467; http:// dx.doi.org/10.1038/45159.
31. Cruz JC, Tseng HC, Goldman JA, Shih H, Tsai LH. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 2003; 40:471-83; PMID:14642273; http://dx.doi.org/10.1016/S0896-6273(03)00627-5.
32. Kim D, Frank CL, Dobbin MM, Tsunemoto RK, Tu W, Peng PL, et al. Deregulation of HDAC1 by p25/ Cdk5 in neurotoxicity. Neuron 2008; 60:803-17; PMID:19081376; http://dx.doi.org/10.1016/j.neuron.2008.10.015.
33. Utreras E, Maccioni R, González-Billault C. Cyclin-dependent kinase 5 activator p35 overexpression and amyloid beta synergism increase apoptosis in cultured neuronal cells. Neuroscience 2009; 161:978-87; PMID:19362124; http://dx.doi.org/10.1016/j.neuroscience.2009.04.002.
34. Lopes JP, Oliveira CR, Agostinho P. Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-β and prion peptides. Cell Cycle 2009; 8:97-104; PMID:19158499; http://dx.doi.org/10.4161/cc.8.1.7506.
35. Song B, Davis K, Liu XS, Lee HG, Smith M, Liu X. Inhibition of Polo-like kinase 1 reduces beta-amyloid-induced neuronal cell death in Alzheimer's disease. Aging (Albany NY) 2011; 3:846-51; PMID:21931181.
36. Busser J, Geldmacher DS, Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J Neurosci 1998; 18:2801-7; PMID:9525997.
37. Jordan-Sciutto KL, Dorsey R, Chalovich EM, Hammond RR, Achim CL. Expression patterns of retinoblastoma protein in Parkinson disease. J Neuropathol Exp Neurol 2003; 62:68-74; PMID:12528819.
38. Tseng HC, Zhou Y, Shen Y, Tsai LH. A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains. FEBS Lett 2002; 523:58-62; PMID:12123804; http://dx.doi.org/10.1016/S0014-5793(02)02934-4.
39. Ferguson KL, Callaghan SM, O'Hare MJ, Park DS, Slack RS. The Rb-CDK4/6 signaling pathway is critical in neural precursor cell cycle regulation. J Biol Chem 2000; 275:33593-600; PMID:10915795; http:// dx.doi.org/10.1074/jbc. M004879200.
40. Kitagawa M, Higashi H, Jung HK, Suzuki-Takahashi I, Ikeda M, Tamai K, et al. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J 1996; 15:7060-9; PMID:9003781.
41. Rubin SM, Gall AL, Zheng N, Pavletich NP. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release. Cell 2005; 123:1093-106; PMID:16360038; http:// dx.doi.org/10.1016/j.cell.2005. 09.044.
42. Gorges LL, Lents NH, Baldassare JJ. The extreme COOH terminus of the retinoblastoma tumor suppressor protein pRb is required for phosphorylation on Thr-373 and activation of E2F. Am J Physiol Cell Physiol 2008; 295:1151-60; PMID:18768921; http:// dx.doi.org/10.1152/ajpcell.00300.2008.
43. Pan W, Cox S, Hoess RH, Grafström RH. A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein. Cancer Res 2001; 61:2885-91; PMID:11306463.
44. Ohshima T, Ogawa M, Veeranna, Hirasawa M, Longenecker G, Ishiguro K, et al. Synergistic contributions of cyclin-dependant kinase 5/p35 and Reelin/ Dab1 to the positioning of cortical neurons in the developing mouse brain. Proc Natl Acad Sci USA 2001; 98:2764-9; PMID:11226314; http://dx.doi. org/10.1073/pnas. 051628498.
45. Hamdane M, Buée L. The complex p25/Cdk5 kinase in neurofibrillary degeneration and neuronal death: the missing link to cell cycle. Biotechnol J 2007; 2:967- 77; PMID:17571276; http://dx.doi.org/10.1002/ biot.200700059.
46. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR. The E2F transcription factor is a cellular target for the RB protein. Cell 1991; 65:1053-61; PMID:1828392; http://dx.doi.org/10.1016/0092- 8674(91)90557-F.
47. Herrup K, Yang Y. Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? Nat Rev Neurosci 2007; 8:368-78; PMID:17453017; http:// dx.doi.org/10.1038/nrn2124.
48. Lopes JP, Agostinho P. Cdk5: multitasking between physiological and pathological conditions. Prog Neurobiol 2011; 94:49-63; PMID:21473899; http:// dx.doi.org/10.1016/j.pneurobio.2011.03.006.
49. 1 phase impairs MCM chromatin loading and inhibits DNA synthesis in mammalian cells. Cell Cycle 2008; 7:2179-88; PMID:18635963; http://dx.doi.org/ 10.4161/cc.7.14.6270.
50. Jaffe H, Vinade L, Dosemeci A. Identification of novel phosphorylation sites on postsynaptic density proteins. Biochem Biophys Res Commun 2004; 321:210-8; PMID:15358237; http://dx.doi.org/10.1016/j.bbrc.2004.06.122.